Identification of HLA‐DQA1 and HLA‐DRB5 as Risk Factors for Multiple Sclerosis: An Epigenome‐Wide Methylation Haplotype Association Analysis
International Journal of Immunogenetics · 2026-06 · 53 (3) · 248-258
DOI: 10.1111/iji.70043 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Immunogenetics, online erschienen am 23.02.2026. Verfasst von Zhenwei Shang und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, China. Hauptthemen laut MEDLINE: HLA-DQ alpha-Chains, Multiple Sclerosis, DNA Methylation, Genetic Predisposition to Disease. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 58 Literaturangaben.
Abstract (Originalsprache)
Multiple sclerosis (MS) is a chronic central nervous system inflammatory disease of autoimmune aetiology. The disease is mostly considered due to a complex interaction between different genetic and environmental factors. DNA methylation is an epigenetic mechanism that can influence gene expression and has the potential to mediate the effects of environmental factors on MS. This study aimed to identify MS risk methylation haplotypes (meplotypes) and their associated genes by integrating epigenome‐wide meplotype association analysis with gene optimisation. We conducted the first epigenome‐wide meplotype association study for MS using methylation data from peripheral blood lymphocytes (PBLs) of 140 MS patients and 139 normal controls. The analytical procedure comprised the following steps: (1) conversion of DNA methylation level into menotypes; (2) identification of methylation disequilibrium (MD) block and performance of meplotype association analysis; (3) screening of risk meplotypes and their mapping to genes; (4) conducting functional analysis of the candidate genes; and (5) final identification of MS risk genes through gene optimisation. Our analysis identified 286 meplotypes across 191 MD blocks that were significantly associated with MS ( p value < 0.05). Of these, 120 meplotypes were found to confer increased risk for MS susceptibility and were mapped to 134 candidate genes. Gene optimisation identified four MS risk meplotypes on three key genes: HLA‐DQA1, HLA‐DRB5 and HLA‐DRB1. These results not only confirm the pivotal role of HLA‐DRB1 in MS but also report, for the first time, an association between MS and DNA methylation patterns in HLA‐DQA1 and HLA‐DRB5. This study demonstrates that epigenome‐wide methylation haplotype analysis offers a powerful and novel perspective for identifying MS‐related genes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, China.
- Faculty of Information Engineering and Automation, Kunming University of Science and Technology, Kunming, China.
ORCID-Profile: Zhenwei Shang, Yongshuai Jiang
Zitieren
APA
Shang, Z., Wang, J., Xu, J., Zhang, M., Lv, H., Jiang, Y., Zhang, R., & Lv, W. (2026). Identification of HLA‐DQA1 and HLA‐DRB5 as Risk Factors for Multiple Sclerosis: An Epigenome‐Wide Methylation Haplotype Association Analysis. International Journal of Immunogenetics, 53(3), 248-258. https://doi.org/10.1111/iji.70043
Vancouver
Shang Z, Wang J, Xu J, Zhang M, Lv H, Jiang Y, et al. Identification of HLA‐DQA1 and HLA‐DRB5 as Risk Factors for Multiple Sclerosis: An Epigenome‐Wide Methylation Haplotype Association Analysis. International Journal of Immunogenetics. 2026;53(3):248-258. doi:10.1111/iji.70043
BibTeX
@article{Shang2026,
author = {Shang, Zhenwei and Wang, Jiacheng and Xu, Jing and Zhang, Mingming and Lv, Hongchao and Jiang, Yongshuai and Zhang, Ruijie and Lv, Wenhua},
title = {Identification of HLA‐DQA1 and HLA‐DRB5 as Risk Factors for Multiple Sclerosis: An Epigenome‐Wide Methylation Haplotype Association Analysis},
journal = {International Journal of Immunogenetics},
year = {2026},
volume = {53},
number = {3},
pages = {248--258},
doi = {10.1111/iji.70043}
}
EUVIMED